Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T ...

The Osaka University study analyzed data from patients who reported health issues between late March and late April 2024.

The National Eligibility cum Entrance Test (NEET) is a competitive medical entrance examination in India for admission to ...

(HealthDay News) — Interstitial cystitis and bladder pain syndrome (IC/BPS) vary in clinical manifestation, according to a study published online in the International Journal of Urology.

This study describes a valuable new model for in vivo manipulation of microglia, exploring how mutations in the Adar1 gene within microglia contribute to Aicardi-Goutières Syndome. The methodology is ...

In a retrospective review of the FDA's Adverse Event Reporting System, which collected data on tenofovir-associated Fanconi syndrome from 2001 to 2006, 164 individuals met the definition for ...

Biomarkers that reliably identify or even predict disease manifestations in systemic lupus erythematosus (SLE) are needed. In a recent issue of the Clinical Journal of the American Society of ...

Kyverna Therapeutics, Inc. (Kyverna, NASDAQ: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, announced that the Company ...